We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva To Continue Selling Generic Vicoprofen After Losing Vs. Abbott At Federal Circuit

Law360 (May 20, 2004, 12:00 AM EDT) -- Israeli generic drug maker Teva Pharmaceutical Industries plans to continue selling its version of Abbott Laboratories' pain medication vicoprofen, despite losing an appeal in a patent dispute.

Teva said the U.S. Court of Appeals for the Federal Circuit has vacated a September 2002 summary judgment which invalidated the patent protecting vicoprofen.

The district court had ruled that the U.S. patent was invalid as obvious, but the Federal Circuit disagreed with the lower court.

“Although the prior art appears to suggest combining an opioid, such as hydrocodone,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.